Time to presentation and mortality outcomes among patients with diabetes and acute myocardial infarction
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: Due to limited real-world evidence on the association between time to presentation (T2P) and outcomes following acute myocardial infarction and diabetes (AMI-DM), we investigated the characteristics of patients with AMI-DM and their outcomes based on their T2P. Methods: 4,455 patients with AMI-DM from a Korean nationwide observational cohort (2011–2015) were divided into early and late presenters according to symptom-to-door time. The effects of T2P on three-year all-cause mortality were estimated using inverse probability of treatment weighting (IPTW) and survival analysis. Results: The incidence of all-cause mortality was consistently higher in late presenters than in early presenters (11.4 vs. 17.2%; p < 0.001). In the IPTW-adjusted dataset, the incidence of all-cause mortality was numerically higher in late presenters than in early presenters (9.1 vs. 12.4%; p = 0.072). In the survival analysis, the cumulative incidence of all-cause mortality was significantly higher in late presenters than in early presenters before and after IPTW. In the subgroup with ST-elevation myocardial infarction, late presenters had a higher incidence of cardiac death than early presenters before (4.8 vs. 10.5%; p < 0.001) and after IPTW (4.2 vs. 9.7%; p = 0.034). In the initial glycated hemoglobin (HbA1c)-stratified analysis, these effects were attenuated in patients with HbA1c ≥ 9.0% before (adjusted hazard ratio [HR]: 1.45, 95% confidence interval [CI]: 0.80-2.64) and after IPTW (adjusted HR: 0.82, 95% CI: 0.40-1.67). Conclusions: Late presentation was associated with higher mortality in patients with AMI-DM; therefore, multifaceted and systematic interventions are needed to decrease pre-hospital delays.
Abstract
Background/Aims: Due to limited real-world evidence on the association between time to presentation (T2P) and outcomes following acute myocardial infarction and diabetes (AMI-DM), we investigated the characteristics of patients with AMI-DM and their outcomes based on their T2P. Methods: 4,455 patients with AMI-DM from a Korean nationwide observational cohort (2011–2015) were divided into early and late presenters according to symptom-to-door time. The effects of T2P on three-year all-cause mortality were estimated using inverse probability of treatment weighting (IPTW) and survival analysis. Results: The incidence of all-cause mortality was consistently higher in late presenters than in early presenters (11.4 vs. 17.2%; p < 0.001). In the IPTW-adjusted dataset, the incidence of all-cause mortality was numerically higher in late presenters than in early presenters (9.1 vs. 12.4%; p = 0.072). In the survival analysis, the cumulative incidence of all-cause mortality was significantly higher in late presenters than in early presenters before and after IPTW. In the subgroup with ST-elevation myocardial infarction, late presenters had a higher incidence of cardiac death than early presenters before (4.8 vs. 10.5%; p < 0.001) and after IPTW (4.2 vs. 9.7%; p = 0.034). In the initial glycated hemoglobin (HbA1c)-stratified analysis, these effects were attenuated in patients with HbA1c ≥ 9.0% before (adjusted hazard ratio [HR]: 1.45, 95% confidence interval [CI]: 0.80-2.64) and after IPTW (adjusted HR: 0.82, 95% CI: 0.40-1.67). Conclusions: Late presentation was associated with higher mortality in patients with AMI-DM; therefore, multifaceted and systematic interventions are needed to decrease pre-hospital delays.
참고문헌 (48)
- Knuuti J, "2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes", Eur Heart J, 41, pp.407~477 (2020)
- Avogaro A, "Glucose-lowering therapy and cardiovascular outcomes in patients with type 2 diabetes mellitus and acute coronary syndrome", Diab Vasc Dis Res, 16, pp.399~414 (2019)
- Lyu YS, "Comparison of SGLT2 inhibitors with DPP-4 inhibitors combined with metformin in patients with acute myocardial infarction and diabetes mellitus", Cardiovasc Diabetol, 22, pp.185~ (2023)
- El-Menyar A, "Atypical presentation of acute coronary syndrome: a significant independent predictor of in-hospital mortality", J Cardiol, 57, pp.165~171 (2011)
- Sheifer SE, "Time to presentation with acute myocardial infarction in the elderly : associations with race, sex, and socioeconomic characteristics", Circulation, 102, pp.1651~1656 (2000)
- Cha JJ, "Clinical outcomes in patients with delayed hospitalization for non-ST-segment elevation myocardial infarction", J Am Coll Cardiol, 79, pp.311~323 (2022)
- Kim JH, "Multicenter cohort study of acute myocardial infarction in Korea - interim analysis of the Korea Acute Myocardial Infarction Registry-National Institutes of Health Registry", Circ J, 80, pp.1427~1436 (2016)
- World Medical Association, "World Medical Association Declaration of Helsinki : ethical principles for medical research involving human subjects", JAMA, 310, pp.2191~2194 (2013)
- Ibanez B, "2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)", Eur Heart J, 39, pp.119~177 (2018)
- Roffi M, "2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)", Eur Heart J, 37, pp.267~315 (2016)
- Stone GW, "Prospective, multicenter study of the safety and feasibility of primary stenting in acute myocardial infarction : in-hospital and 30-day results of the PAMI stent pilot trial. Primary Angioplasty in Myocardial Infarction Stent Pilot Trial Investigators", J Am Coll Cardiol, 31, pp.23~30 (1998)
- Ellis SG, "Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group", Circulation, 82, pp.1193~1202 (1990)
- Lee M, "Gender differences in clinical outcomes of acute myocardial infarction undergoing percutaneous coronary intervention : insights from the KAMIR-NIH Registry", J Geriatr Cardiol, 17, pp.680~693 (2020)
- Cho KH, "Long-term outcomes of patients with late presentation of ST-segment elevation myocardial infarction", J Am Coll Cardiol, 77, pp.1859~1870 (2021)
- Austin PC, "An introduction to propensity score methods for reducing the effects of confounding in observational studies", Multivariate Behav Res, 46, pp.399~424 (2011)
- Austin PC, "Moving towards best practice when using inverse probability of treatment weighting(IPTW)using the propensity score to estimate causal treatment effects in observational studies", Stat Med, 34, pp.3661~3679 (2015)
- Brieger D, "Acute coronary syndromes without chest pain, an underdiagnosed and undertreated high-risk group: insights from the Global Registry of Acute Coronary Events", Chest, 126, pp.461~469 (2004)
- Wenger NK, "Angina in women", Curr Cardiol Rep, 12, pp.307~314 (2010)
- Lee SH, "Pre-hospital delay and emergency medical services in acute myocardial infarction", Korean J Intern Med, 35, pp.119~132 (2020)
- Pampel FC, "Global patterns and determinants of sex differences in smoking", Int J Comp Sociol, 47, pp.466~487 (2006)
- Oh S, "Association between baseline smoking status and clinical outcomes following myocardial infarction", Front Cardiovasc Med, 9, pp.918033~ (2022)
- Bailleul C, "Prognostic impact of prepercutaneous coronary intervention TIMI flow in patients with ST-segment and non-ST-segment elevation myocardial infarction: results from the FAST-MI 2010registry", Arch Cardiovasc Dis, 111, pp.101~108 (2018)
- Karwowski J, "Total coronary occlusion of infarct-related arteries in patients with non-ST-elevation myocardial infarction undergoing percutaneous coronary revascularisation", Kardiol Pol, 75, pp.108~116 (2017)
- Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology(ESC), "ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation", Eur Heart J, 33, pp.2569~2619 (2012)
- Oh S, "Outcomes of nonagenarians with acute myocardial infarction with or without coronary intervention", J Clin Med, 11, pp.1593~ (2022)
- Nilsson G, "Pre-hospital delay in patients with first time myocardial infarction : an observational study in a northern Swedish population", BMC Cardiovasc Disord, 16, pp.93~ (2016)
- Yoon CW, "Comparisons of prehospital delay and related factors between acute ischemic stroke and acute myocardial infarction", J Am Heart Assoc, 11, pp.e023214~ (2022)
- Fu R, "Clinical significance of diabetes on symptom and patient delay among patients with acute myocardial infarction-an analysis from China Acute Myocardial Infarction(CAMI)registry", J Geriatr Cardiol, 16, pp.395~400 (2019)
- Wackers FJ, "Detection of silent myocardial ischemia in asymptomatic diabetic subjects:the DIAD study", Diabetes Care, 27, pp.1954~1961 (2004)
- Kim I, "Prognostic significance of non-chest pain symptoms in patients with non-ST-segment elevation myocardial infarction", Korean J Intern Med, 33, pp.1111~1118 (2018)
- Oh S, "Long-term outcomes in ST-elevation myocardial infarction patients treated according to hospital visit time", Korean J Intern Med, 37, pp.605~617 (2022)
- Sherwani SI, "Significance of HbA1c test in diagnosis and prognosis of diabetic patients", Biomark Insights, 11, pp.95~104 (2016)
- Kim YH, "Effects of delayed hospitalization on the 3-year clinical outcomes of patients with or without diabetes who had non-ST-segment-elevation myocardial infarction and underwent new-generation drug-eluting stent implantation", Catheter Cardiovasc Interv, 101, pp.1014~1027 (2023)
- Mather AN, "Relationship of dysglycemia to acute myocardial infarct size and cardiovascular outcome as determined by cardiovascular magnetic resonance", J Cardiovasc Magn Reson, 12, pp.61~ (2010)
- Avogaro A, "Endothelial dysfunction in diabetes : the role of reparatory mechanisms", Diabetes Care, 34(Suppl 2), pp.S285~S290 (2011)
- Burgess S, "Cardiac mortality, diabetes mellitus, and multivessel disease in ST elevation myocardial infarction", Int J Cardiol, 323, pp.13~18 (2021)
- Kim YH, "Effect of delayed hospitalization on 3-year clinical outcomes according to renal function in patients with non-ST-segment elevation myocardial infarction", Cardiol J (2023)[DOI]
- Basalay MV, "Targeting myocardial ischaemic injury in the absence of reperfusion", Basic Res Cardiol, 115, pp.63~ (2020)
- Kim YH, "Outcomes of early versus delayed invasive strategy in older adults with non-ST-segment elevation myocardial infarction", Sci Rep, 12, pp.11429~ (2022)
- Panoulas V, "Impact of early(≤24h)versus delayed(>24 h)intervention in patients with non-ST segment elevation myocardial infarction : an observational study of 20, 882 patients from the London Heart Attack Group", Cardiovasc Revasc Med, 22, pp.3~7 (2021)
- Li Y, "Immediate", early vs. delayed invasive strategy for patients with non-ST-segment elevation acute coronary syndromes : a systematic review and meta-analysis, 2017, pp.8, 952~
- Ronco C, "Cardiorenal syndrome", J Am Coll Cardiol, 52, pp.1527~1539 (2008)
- Kim MC, "Long-term clinical outcomes of transient and persistent no reflow phenomena following percutaneous coronary intervention in patients with acute myocardial infarction", Korean Circ J, 46, pp.490~498 (2016)
- Ibáñez B, "Evolving therapies for myocardial ischemia", reperfusion injury, 2015, pp.65, 1454~1471
- ), "Am J Cardiol", 2018, 1285~1292
- Canto AJ, "Differences in symptom presentation and hospital mortality according to type of acute myocardial infarction", Am Heart J, 163, pp.572~579 (2012)
- Cho JY, "Comparison of outcomes of patients with painless versus painful ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention", Am J Cardiol, 109, pp.337~343 (2012)
- Fujino M, "Impact of symptom presentation on in-hospital outcomes in patients with acute myocardial infarction", J Cardiol, 70, pp.29~34 (2017)